Main menu


Asia/Pacific: Australia to spend on vaccines for wider region

CANBERRA, Australia (AP) — Australia has announced it will spend 500 million Australian dollars ($351 million) to secure COVID-19 vaccines for the Pacific and Southeast Asia “as part of a shared recovery for our region from the pandemic.”

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Contract Tracing Problems: People Increasingly, ‘Have No Idea’ how they contracted COVID-19.

... As the coronavirus soars across the country, smashing daily records and surpassing nine million cases nationwide, tracing the path of the pandemic in the United States is no longer simply challenging. It has become nearly impossible.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVID-19 Testing and Cases in Immigration Detention Centers: Infections are rising

ANALYSIS:Trump Baselessly Accuses Doctors Of Overreporting Covid Deaths For Financial Gain

THE SCIENCE OF SUPERSPREADING Why preventing hot spots of transmission is key to stopping the COVID-19 pandemic

 

THE SCIENCE OF SUPERSPREADING

 

 Click on above link for graphics illustrating superspreading events.

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

EU leaders link arms for long coronavirus fight

EU leaders pledged Thursday night to step up cooperation on every aspect of their fight against the coronavirus — by keeping borders open, improving testing and contact tracing, monitoring critical care capacity and arranging cross-border patient transfers if necessary, and developing plans for the swift manufacture and distribution of vaccines.

During a roughly three-hour videoconference, the 27 heads of state and government, and the presidents of the Commission and Council, also conferred about pandemic “fatigue” as citizens grow increasingly sick and tired of the world being ill or at risk. Some leaders seemed sick and tired of it all themselves.

But overall, even as they acknowledged clear failures in the early months of the outbreak as well as in preventing a second wave of infections, the leaders voiced determination and seemed prepared to hunker down for a months-long fight. And they urged the EU’s 440 million citizens to do their part amid renewed lockdowns, curfews and other containment measures.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

OVEREVIEW: The Pandemic Is in Uncharted Territory

The United States set a new record for reported cases this week, breaking 500,000 for the first time in the pandemic as the third surge continued to build across nearly every state in the country.

Problem, Solution, SitRep, or ?: 

First, coronavirus infections increased. Then, hospitalizations. Now, deaths are on the rise.

Singapore firm invents coronavirus breathalyser with results in seconds

SINGAPORE (Reuters) - A company in Singapore has developed a breathalyser test for the new coronavirus which it says will enable people to know whether they are infected in under a minute.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

2nd study testing a COVID-19 antibody drug has a setback

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. coronavirus cases cross nine million: Some Governors resist additional steps --Reuters tally

(Reuters) - U.S. coronavirus cases crossed the 9 million mark on Friday, rising by 1 million in two weeks as the world’s worst-affected country faces a resurgence in the pandemic just ahead of elections.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Why Autopsies Are Proving Crucial During Covid-19

New CDC study shows how rapidly COV-10 can spread in a household

Slovakia to test all adults for SARS-CoV-2

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Remsdesvir: Some experts troubled about FDA approval for COVID-19 treatment

The United States reached a milestone, of sorts, when last week the Food and Drug Administration approved the first treatment for Covid-19.

The drug is called Veklury, although most people know it by its scientific name, remdesivir.

On Wednesday, its manufacturer, Gilead Sciences, said that remdesivir, which has been authorized for emergency use since the spring, had brought in $873 million in revenues so far this year and that it was the company’s second-best-selling drug in the third quarter, behind its H.I.V. drug, Biktarvy.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Philadelphia RSS
howdy folks
Page loaded in 1.866 seconds.